Search research articles
Contact Us
Filters
Showing results (21-30 of 96) with videos related to
Page
of 10
Sort By:
Virology
|
August 1, 1984
Recombinants of Mahoney and Sabin strain poliovirus type 1: analysis of in vitro phenotypic markers and evidence that resistance to guanidine maps in the nonstructural proteins
E A Emini, J Leibowitz, D C Diamond, et al.
Journal of Virology
|
May 1, 1983
Functional basis of poliovirus neutralization determined with monospecific neutralizing antibodies
E A Emini, S Y Kao, A J Lewis, et al.
Journal of Medical Virology
|
February 1, 1989
Vero cell-expressed Epstein-Barr virus (EBV) gp350/220 protects marmosets from EBV challenge
E A Emini, W A Schleif, M Silberklang, et al.
Journal of Virology
|
September 1, 1982
Poliovirus neutralization epitopes: analysis and localization with neutralizing monoclonal antibodies
E A Emini, B A Jameson, A J Lewis, et al.
Virology
|
January 15, 1983
Identification of a poliovirus neutralization epitope through use of neutralizing antiserum raised against a purified viral structural protein
E A Emini, A J Dorner, L F Dorner, et al.
Virology
|
April 15, 1981
Isolation and characterization of temperature-sensitive mutants of Venezuelan encephalitis virus
B A Pancake, Z P Harsanyi, M E Wiebe, et al.
Archives of Virology. Supplementum
|
January 1, 1994
The genetic and functional basis of HIV-1 resistance to nonnucleoside reverse transcriptase inhibitors
E A Emini, V W Byrnes, J H Condra, et al.
Journal of Virological Methods
|
July 1, 1988
A microtiter cell-culture assay for the determination of anti-human immunodeficiency virus neutralizing antibody activity
G A Robertson, B M Kostek, W A Schleif, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 5, 1994
Human immunodeficiency virus 1 (HIV-1)-specific reverse transcriptase (RT) inhibitors may suppress the replication of specific drug-resistant (E138K)RT HIV-1 mutants or select for highly resistant (Y181C-->C181I)RT HIV-1 mutants
J Balzarini, A Karlsson, V V Sardana, et al.
The Journal of Infectious Diseases
|
August 19, 2000
Drug resistance and predicted virologic responses to human immunodeficiency virus type 1 protease inhibitor therapy
J H Condra, C J Petropoulos, R Ziermann, et al.
Page
of 10
Search research articles
Search
Showing results (21-30 of 96) with videos related to
Sort By:
Page
of 10
Virology
|
August 1, 1984
Recombinants of Mahoney and Sabin strain poliovirus type 1: analysis of in vitro phenotypic markers and evidence that resistance to guanidine maps in the nonstructural proteins
E A Emini, J Leibowitz, D C Diamond, et al.
Journal of Virology
|
May 1, 1983
Functional basis of poliovirus neutralization determined with monospecific neutralizing antibodies
E A Emini, S Y Kao, A J Lewis, et al.
Journal of Medical Virology
|
February 1, 1989
Vero cell-expressed Epstein-Barr virus (EBV) gp350/220 protects marmosets from EBV challenge
E A Emini, W A Schleif, M Silberklang, et al.
Journal of Virology
|
September 1, 1982
Poliovirus neutralization epitopes: analysis and localization with neutralizing monoclonal antibodies
E A Emini, B A Jameson, A J Lewis, et al.
Virology
|
January 15, 1983
Identification of a poliovirus neutralization epitope through use of neutralizing antiserum raised against a purified viral structural protein
E A Emini, A J Dorner, L F Dorner, et al.
Virology
|
April 15, 1981
Isolation and characterization of temperature-sensitive mutants of Venezuelan encephalitis virus
B A Pancake, Z P Harsanyi, M E Wiebe, et al.
Archives of Virology. Supplementum
|
January 1, 1994
The genetic and functional basis of HIV-1 resistance to nonnucleoside reverse transcriptase inhibitors
E A Emini, V W Byrnes, J H Condra, et al.
Journal of Virological Methods
|
July 1, 1988
A microtiter cell-culture assay for the determination of anti-human immunodeficiency virus neutralizing antibody activity
G A Robertson, B M Kostek, W A Schleif, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 5, 1994
Human immunodeficiency virus 1 (HIV-1)-specific reverse transcriptase (RT) inhibitors may suppress the replication of specific drug-resistant (E138K)RT HIV-1 mutants or select for highly resistant (Y181C-->C181I)RT HIV-1 mutants
J Balzarini, A Karlsson, V V Sardana, et al.
The Journal of Infectious Diseases
|
August 19, 2000
Drug resistance and predicted virologic responses to human immunodeficiency virus type 1 protease inhibitor therapy
J H Condra, C J Petropoulos, R Ziermann, et al.
Page
of 10